| Irena Prodan Žitnik was born in 1976 in Ljubljana. In 2000 she graduated at the Faculty of Pharmacy and in 2009 she finished her PhD under the supervision of prof. Jana Lukač Bajalo with thesis Study of impaired galactose metabolism and lactase persistance in relation to ovarian cancer risk. Since 2002, she is employed at the Faculty of Pharmacy, first as a young researcher and from 2009 on as an assistant. Her research fields are Pharmacogenomics of tyrosine kinase inhibitors in treatment of chronic mieloid leukemia and Molecular causes of certain metabolic diseases. She supervises laboratory practice in the following courses: Clinical Chemistry, Clinical Biochemistry and Cell biology and genetics. |